Investors Title (NASDAQ:ITIC - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $241.00 and traded as high as $252.46. Investors Title shares last traded at $246.75, with a volume of 78,398 shares.
Wall Street Analyst Weigh In
Separately, StockNews.com lowered shares of Investors Title from a "buy" rating to a "hold" rating in a report on Monday, May 12th.
Check Out Our Latest Analysis on Investors Title
Investors Title Stock Performance
The business has a 50-day simple moving average of $235.61 and a two-hundred day simple moving average of $241.00. The stock has a market cap of $465.37 million, a price-to-earnings ratio of 15.02 and a beta of 0.91.
Investors Title (NASDAQ:ITIC - Get Free Report) last announced its quarterly earnings data on Thursday, May 8th. The insurance provider reported $1.67 earnings per share (EPS) for the quarter. Investors Title had a return on equity of 11.84% and a net margin of 12.03%.
Investors Title Cuts Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 24th were issued a $0.46 dividend. The ex-dividend date was Monday, March 24th. This represents a $1.84 dividend on an annualized basis and a dividend yield of 0.75%. Investors Title's payout ratio is 11.72%.
Institutional Investors Weigh In On Investors Title
Several hedge funds have recently bought and sold shares of ITIC. Jane Street Group LLC bought a new position in shares of Investors Title during the 1st quarter worth approximately $571,000. AQR Capital Management LLC boosted its holdings in shares of Investors Title by 8.0% during the 1st quarter. AQR Capital Management LLC now owns 1,917 shares of the insurance provider's stock worth $462,000 after buying an additional 142 shares during the period. Royal Bank of Canada boosted its holdings in shares of Investors Title by 2.3% during the 1st quarter. Royal Bank of Canada now owns 3,937 shares of the insurance provider's stock worth $949,000 after buying an additional 88 shares during the period. Trexquant Investment LP acquired a new position in Investors Title in the 1st quarter valued at about $244,000. Finally, Aristides Capital LLC raised its holdings in Investors Title by 5.3% in the 1st quarter. Aristides Capital LLC now owns 11,920 shares of the insurance provider's stock valued at $2,874,000 after acquiring an additional 600 shares during the period. 41.40% of the stock is currently owned by institutional investors and hedge funds.
Investors Title Company Profile
(
Get Free Report)
Investors Title Company engages in the issuance of residential and commercial title insurance for residential, institutional, commercial, and industrial properties. The company underwrites land title insurance for owners and mortgagees as a primary insurer; and assumes the reinsurance of title insurance risks from other title insurance companies.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Investors Title, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Investors Title wasn't on the list.
While Investors Title currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.